News Releases :: Sutro Biopharma, Inc. (STRO)

Feb 27, 2020 7:00 am EST

Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference

Feb 5, 2020 7:30 am EST

Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development

Jan 9, 2020 7:00 am EST

Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference

Jan 8, 2020 9:26 am EST

Sutro Biopharma Appoints James Panek to Board of Directors

Nov 26, 2019 7:00 am EST

Sutro Biopharma to Participate in the 31st Annual Piper Jaffray Healthcare Conference

Nov 19, 2019 7:00 am EST

Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference

Nov 8, 2019 7:00 am EST

Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments

Oct 29, 2019 7:00 am EDT

Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer

Oct 16, 2019 4:35 pm EDT

Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Oct 8, 2019 7:00 am EDT

Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors